{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:04:13Z","timestamp":1794488653797,"version":"4.9.1"},"reference-count":23,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2026,11,1]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>The optimal surgical approach for oncological thoracoabdominal esophagectomy for adenocarcinoma is unclear. Robot-assisted minimally invasive esophagectomy (RAMIE) may facilitate a more extensive lymphadenectomy compared with conventional minimally invasive esophagectomy (MIE), which is crucial to achieve a favorable oncological outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine whether RAMIE results in a higher yield of resected lymph nodes compared with conventional MIE in patients undergoing surgery for esophageal or esophagogastric junction adenocarcinoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This was a phase 3 randomized clinical trial conducted between January 2021 and March 2025 at 4 high-volume tertiary referral centers in Mainz, Germany; Amsterdam, the Netherlands; Zurich, Switzerland; and Cologne, Germany. Patients with resectable adenocarcinoma of the esophagus or esophagogastric junction staged as cT1-4a, cN0-3, and cM0 were included. Both primary surgery and multimodal treatment settings were eligible. A total of 218 patients were initially randomized, 202 of whom completed the study and underwent transthoracic esophagectomy with follow-up up to 5 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Participants were randomly assigned (1:1) to RAMIE or conventional MIE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary end point was the number of resected lymph nodes, planned a priori and analyzed on a modified intention-to-treat basis. Secondary measures included luminal R0 resection rates, postoperative complication rates, 90-day mortality, and 1-year survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Between 2021 and 2025, 218 patients were included in the study, 202 of whom (mean [SD] age, 64.8 [10.1] years; 181 [89.6%] male) underwent transthoracic esophagectomy (101 RAMIE and 101 MIE). The median number of resected lymph nodes was significantly higher in RAMIE compared to MIE (36 vs 32;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.005). Luminal R0 resection was 99.0% with RAMIE and 97.0% with MIE. Rates of postoperative complications were similar between groups; 90-day mortality was 1.0% in the RAMIE group and 3.0% in the MIE group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.62). There was no difference in survival after 1 year.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this study, robotic esophagectomy provided a more radical lymphadenectomy compared to conventional minimally invasive esophagectomy with equal results for surgical safety. These results support the use of robotic esophagectomy as a standard approach for adenocarcinoma of the esophagus or esophagogastric junction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT04306458\">NCT04306458<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamasurg.2026.4478","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:31:41Z","timestamp":1790782301000},"page":"1135","source":"Crossref","is-referenced-by-count":1,"title":["Robotic vs Thoracolaparoscopic Esophagectomy for Esophageal Cancer"],"prefix":"10.1001","volume":"161","author":[{"given":"Felix","family":"Berlth","sequence":"first","affiliation":[{"name":"Department of General, Visceral and Transplant Surgery, University Hospital Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne S.","family":"Gisbertz","sequence":"additional","affiliation":[{"name":"Department of Surgery, Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands"},{"name":"Cancer Center Amsterdam, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Tagkalos","sequence":"additional","affiliation":[{"name":"University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edin","family":"Hadzijusufovic","sequence":"additional","affiliation":[{"name":"University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Magnus","family":"Schneider","sequence":"additional","affiliation":[{"name":"Esophageal Cancer Center and Digestive Oncology Tumor Center, Hirslanden Medical Center, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Fuchs","sequence":"additional","affiliation":[{"name":"Department of General, Visceral, Cancer and Transplantation Surgery, University Hospital of Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark I.","family":"van Berge Henegouwen","sequence":"additional","affiliation":[{"name":"Department of Surgery, Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands"},{"name":"Cancer Center Amsterdam, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir J.","family":"Lozanovski","sequence":"additional","affiliation":[{"name":"University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle P.","family":"Ruurda","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Medical Center Utrecht, University of Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Goense","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Medical Center Utrecht, University of Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Schiesser","sequence":"additional","affiliation":[{"name":"Esophageal Cancer Center and Digestive Oncology Tumor Center, Hirslanden Medical Center, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Bruns","sequence":"additional","affiliation":[{"name":"Department of General, Visceral, Cancer and Transplantation Surgery, University Hospital of Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hauke","family":"Lang","sequence":"additional","affiliation":[{"name":"University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"van Hillegersberg","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Medical Center Utrecht, University of Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P.","family":"Grimminger","sequence":"additional","affiliation":[{"name":"University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"7","key":"soi260066r1","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/ijc.35278","article-title":"The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide.","volume":"156","author":"Filho","year":"2025","journal-title":"Int J Cancer"},{"issue":"4","key":"soi260066r2","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/NEJMoa2409408","article-title":"Perioperative chemotherapy or preoperative chemoradiotherapy in esophageal cancer.","volume":"392","author":"Hoeppner","year":"2025","journal-title":"N Engl J Med"},{"issue":"2","key":"soi260066r3","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1056\/NEJMoa1805101","article-title":"Hybrid minimally invasive esophagectomy for esophageal cancer.","volume":"380","author":"Mariette","year":"2019","journal-title":"N Engl J Med"},{"issue":"9829","key":"soi260066r4","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/S0140-6736(12)60516-9","article-title":"Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial.","volume":"379","author":"Biere","year":"2012","journal-title":"Lancet"},{"issue":"8","key":"soi260066r5","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1007\/s00268-015-3100-y","article-title":"Quality of life and late complications after minimally invasive compared to open esophagectomy: results of a randomized trial.","volume":"39","author":"Maas","year":"2015","journal-title":"World J Surg"},{"issue":"4","key":"soi260066r6","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/SLA.0000000000003031","article-title":"Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer: a randomized controlled trial.","volume":"269","author":"van der Sluis","year":"2019","journal-title":"Ann Surg"},{"issue":"2","key":"soi260066r7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/SLA.0000000000002824","article-title":"Prognostic value of lymph node yield on overall survival in esophageal cancer patients: a systematic review and meta-analysis.","volume":"269","author":"Visser","year":"2019","journal-title":"Ann Surg"},{"issue":"5","key":"soi260066r8","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1097\/SLA.0000000000002389","article-title":"Impact of lymph node yield on overall survival in patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy for cancer: a population-based cohort study in the Netherlands.","volume":"266","author":"Visser","year":"2017","journal-title":"Ann Surg"},{"issue":"4","key":"soi260066r9","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1097\/SLA.0b013e318188c474","article-title":"The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection.","volume":"248","author":"Peyre","year":"2008","journal-title":"Ann Surg"},{"issue":"1","key":"soi260066r10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2025.110531","article-title":"Comparing outcomes following open, hybrid, minimally invasive, and robotic-assisted esophagectomy: a systematic review.","volume":"52","author":"Dunne","year":"2026","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"soi260066r11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/SLA.0000000000005782","article-title":"Robotic versus conventional minimally invasive esophagectomy for esophageal cancer: a meta-analysis.","volume":"278","author":"Zhang","year":"2023","journal-title":"Ann Surg"},{"issue":"10489","key":"soi260066r12","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/S0140-6736(25)00672-5","article-title":"CONSORT 2025 statement: updated guideline for reporting randomised trials.","volume":"405","author":"Hopewell","year":"2025","journal-title":"Lancet"},{"issue":"1","key":"soi260066r13","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1186\/s12885-021-08780-x","article-title":"Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial).","volume":"21","author":"Tagkalos","year":"2021","journal-title":"BMC Cancer"},{"issue":"11","key":"soi260066r14","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1046\/j.1365-2168.1998.00940.x","article-title":"Classification of adenocarcinoma of the oesophagogastric junction.","volume":"85","author":"Siewert","year":"1998","journal-title":"Br J Surg"},{"issue":"1","key":"soi260066r15","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1186\/s12885-019-5761-7","article-title":"Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational study.","volume":"19","author":"Hagens","year":"2019","journal-title":"BMC Cancer"},{"issue":"2","key":"soi260066r16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"issue":"7","key":"soi260066r17","doi-asserted-by":"publisher","DOI":"10.1093\/bjs\/znae143","article-title":"Multicentre randomized clinical trial on robot-assisted versus video-assisted thoracoscopic oesophagectomy (REVATE trial).","volume":"111","author":"Chao","year":"2024","journal-title":"Br J Surg"},{"issue":"12","key":"soi260066r18","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/S2468-1253(25)00207-9","article-title":"Thoracoscopic versus open oesophagectomy for patients with oesophageal cancer (JCOG1409 MONET): a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial.","volume":"10","author":"Takeuchi","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"soi260066r19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/SLA.0b013e31817bbe59","article-title":"Total number of resected lymph nodes predicts survival in esophageal cancer.","volume":"248","author":"Altorki","year":"2008","journal-title":"Ann Surg"},{"issue":"28","key":"soi260066r20","doi-asserted-by":"publisher","first-page":"7114","DOI":"10.1200\/JCO.2005.14.621","article-title":"Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database.","volume":"23","author":"Smith","year":"2005","journal-title":"J Clin Oncol"},{"issue":"6","key":"soi260066r21","doi-asserted-by":"publisher","first-page":"e1129","DOI":"10.1097\/SLA.0000000000003772","article-title":"The effect of postoperative complications after minimally invasive esophagectomy on long-term survival: an international multicenter cohort study.","volume":"274","author":"Fransen","year":"2021","journal-title":"Ann Surg"},{"issue":"1","key":"soi260066r22","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1186\/s12885-020-07388-x","article-title":"RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction\u2014a randomized phase III joint study of the AIO, ARO and DGAV.","volume":"20","author":"Lorenzen","year":"2020","journal-title":"BMC Cancer"},{"issue":"4","key":"soi260066r23","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1470-2045(25)00027-0","article-title":"Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial.","volume":"26","author":"van der Wilk","year":"2025","journal-title":"Lancet Oncol"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2854536\/jamasurgery_berlth_2026_oi_260066_1794242233.2921.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T16:01:23Z","timestamp":1794412883000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2854536"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,11,1]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2026.4478","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11,1]]}}}